Bacillus anthracis
- PMID: 12610093
- PMCID: PMC1769905
- DOI: 10.1136/jcp.56.3.182
Bacillus anthracis
Abstract
The events of 11 September 2001 and the subsequent anthrax outbreaks have shown that the West needs to be prepared for an increasing number of terrorist attacks, which may include the use of biological warfare. Bacillus anthracis has long been considered a potential biological warfare agent, and this review will discuss the history of its use as such. It will also cover the biology of this organism and the clinical features of the three disease forms that it can produce: cutaneous, gastrointestinal, and inhalation anthrax. In addition, treatment and vaccination strategies will be reviewed.
References
-
- Bush LM, Abrams BH, Beall A, et al. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001;345:1607–10. - PubMed
-
- Spencer RC, Wilcox MH. Agents of biological warfare. Rev Med Microbiol 1993;4:138–43.
-
- Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon. JAMA 1999;281:1735–45. - PubMed
-
- Spencer RC, Lightfoot NF. Preparedness and response to bioterrorism. J Infect 2001;43:104–10. - PubMed
-
- Redmond C, Pearce MJ, Manchee RJ, et al. Deadly relic of the Great War. Nature 1998;393:747–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical